February, 2024
February 2024
OncoInfluencers: Dialogue with Françoise Meunier, hosted by Gevorg Tamamyan
Nov 13, 2023, 14:22

OncoInfluencers: Dialogue with Françoise Meunier, hosted by Gevorg Tamamyan

Join us on OncoDaily for an inspiring episode of “Oncolnfluencers,” where host Dr. Gevorg Tamamyan sits down with one of the giants in oncology Dr. Françoise Meunier. In this captivating interview, Dr. Meunier shares her remarkable journey of transforming the European Organisation for Research and Treatment of Cancer (EORTC) into a prominent multinational, pan-European institution.

In the interview, Dr. Meunier also explores her current efforts on the “Right to be Forgotten” initiative for cancer survivors. Her insights and leadership advice are particularly valuable for young specialists eager to make their impact in the field of oncology.

Additionally, mark your calendars for February 15, 2024, as Dr. Meunier organizes the High-Level Conference on Ending Financial Discrimination against Cancer Survivors in Brussels. This pivotal event promises to be a milestone in advocating for the rights and well-being of cancer survivors.

For more information about this important event, follow the link.
Don’t miss this opportunity to hear from one of the leading voices in oncology on OncoDaily.

Dr. Françoise Meunier has dedicated her professional life to improving the survival and quality of life of cancer patients. Dr. Meunier received her medical degree from the Université Libre de Bruxelles (ULB) (magna cum laude) and completed a research fellowship at Memorial Sloan-Kettering Cancer Center (New York, 1977-1978, Fulbright award). She holds a Master’s Degree in Medical Oncology (1976) and Internal Medicine (1979), and a PhD (1985) at the ULB. She is certified as Pharmaceutical Medicine specialist (Faculty of Pharmaceutical Medicine, UK) as well as in Belgium and she is a Fellow of the Royal College of Physicians (UK). She is a member of the Belgian Royal Academy of Medicine since 2006. In 2007, she was conferred the title of Baroness by His Majesty, The King Albert II of Belgium. Dr. Meunier served as EORTC Director General from 1991 through 2015 and oversaw the growth of the EORTC into an international world class cancer clinical research infrastructure. Upon stepping down as Director General in 2015, Françoise remained active as EORTC Director Special Projects until November 9, 2018 where she was a driving force behind activities such as EORTC cancer survivorship initiatives. Since 2014, she has been leading an initiative on the Right to be Forgotten for cancer survivors, advocating for the creation of a harmonised European legal framework to tackle discrimination against cancer survivors. In November 2018, Françoise Meunier founded a European Initiative on Ending Financial Discrimination Against Cancer Survivors.

The host, Dr. Gevorg Tamamyan is the Editor-in-chief of OncoDaily, Head of the Pediatric Cancer and Blood Disorders Center of Armenia, Chairman and Professor of the Department of Hematology and Pediatric Oncology at Yerevan State Medical University, CEO of the Immune Oncology Research Institute, President-Elect of the Pediatric Oncology East and Mediterranean (POEM) Group. He is also the Adviser to the Rector of YSMU and to the Director of the Yeolyan Hematology and Oncology Center. He is a Co-Founder and Board Member of the Armenian Association of Hematology and Oncology, City of Smile Charitable Foundation, Co-Founder and Chairman of the Board of the Institute of Cancer and Crisis, the Former President of the Harvard Club of Armenia.

Dr. Tamamyan is the Past-Chair of the American Society of Clinical Oncology (ASCO) IDEA Steering Group and International Society of Pediatric Oncology (SIOP) PODC Supportive care WG, Ambassador of the Society of Hematologic Oncology. He was selected for the ASCO Leadership Development Program and currently is a member of the ASCO International Committee. He is a recipient of numerous awards and distinctions, among them the ASCO IDEA and LIFe Awards, 40 under 40 in Cancer Award, he was recognized as a Young Leader of the International Agency for Cancer Research (IARC) and Union for International Cancer Control (UICC).